Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

X4 Pharmaceuticals (XFOR) Long-Term Debt Issuances (2018 - 2023)

X4 Pharmaceuticals (XFOR) has disclosed Long-Term Debt Issuances for 4 consecutive years, with $22.5 million as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Long-Term Debt Issuances changed N/A year-over-year to $22.5 million, compared with a TTM value of $22.5 million through Dec 2024, changed 0.0%, and an annual FY2024 reading of $20.0 million, down 11.11% over the prior year.
  • Long-Term Debt Issuances was $22.5 million for Q3 2023 at X4 Pharmaceuticals, up from $7.5 million in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $22.5 million in Q3 2023 and bottomed at $4.9 million in Q1 2020.
  • Average Long-Term Debt Issuances over 3 years is $11.2 million, with a median of $8.7 million recorded in 2019.